INDUCTION HEALTHCARE GROUP
PLC
Material new contract with North Central
London Integrated Care System
Notice of Interim Results and Investor
Presentation
London, UK - 30 October 2024:
Induction Healthcare Group PLC ("Induction", the
"Company", or the "Group"; AIM: INHC), a leading
digital health platform driving transformation of healthcare
systems, has signed a contract worth £1.5m to transform patient
access to diagnostic tests across the North Central London
Integrated Care System.
This project will deliver
significant enhancements to Induction's integrated platform which
will connect the Royal Free London NHS Foundation
Trust, Whittington Health NHS Trust, and their corresponding
Community Diagnostics Centres in Wood Green and Finchley. The
platform will digitise diagnostic referrals and booking and
will:
·
Allow for integrated electronic
referrals between the different electronic patient record systems
used across the Integrated Care System ("ICS");
· Give Trusts
direct access to Community Diagnostic Centre appointment slots to
book tests directly for patients;
· Enable patients
to manage and self-book their diagnostic tests, as well as access
information about their visit;
· Collect data on
patient 'no shows' to provide insight on initiatives to reduce
missed appointments; and
· Allow smart
scheduling (including same-day and multi-modality bookings) to be
created and managed.
Induction CEO, Paul
Tambeau, said: "Induction
will be the first portal provider to integrate disparate electronic
systems across a region to facilitate diagnostic tests for
patients, while at the same time giving patients greater control
over their care. Induction will own the platform IP. Digitising and
individualising care pathways across an ICS aligns with our renewed
corporate strategy, and we believe that this contract provides a
basis for growth into the future. I look forward to providing a
trading update with the Interim results on 5 November."
Induction is delivering this as a professional
services contract to fund platform development, given that the
functionality will be relevant to many other Integrated Care
Systems. The majority of the revenue will be recognised in
FY25.
Interim Results
Induction will release Interim
Results for the 6 months ended 30 September 2024 on 5 November
2024. Paul Tambeau, CEO, and John McIntosh, CFO, will provide a
live presentation via Investor Meet Company on 05 Nov 2024, 15:00
GMT. The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your
Investor Meet Company dashboard up until 04 Nov 2024, 09:00 GMT, or
at any time during the live presentation.
Investors can sign up to Investor
Meet Company for free and add to meet INDUCTION HEALTHCARE GROUP
PLC via:
https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor.
Investors who already follow Induction on the Investor Meet Company
platform will automatically be invited.
Enquiries
|
Induction
Christopher Samler, Chair
Paul Tambeau, Chief Executive
Officer
|
+44 (0)7712 194092
+44 (0)7983 104443
|
|
|
|
|
|
|
Singer Capital Markets (Nominated Adviser and
Broker)
|
+44 (0)20 7496 3000
|
|
|
Philip Davies
Jalini Kalaravy
|
|
|
About Induction
- www.inductionhealthcare.com
Induction (AIM: INHC) Induction
delivers a suite of software solutions that transforms care
delivery and the patient journey through hospital. Our system-wide
applications help healthcare providers and administrators to
deliver care at any stage remotely as well as face-to-face - giving
the communities they serve greater flexibility, control and ease of
access. Purpose-built for integration with leading Electronic
Medical Record (EMR) platforms, our products offer immediate
stand-alone value that becomes even greater when integrated with
pre-existing systems.
Used at scale by national and
regional healthcare systems, as well non-health government
services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital
in the British Isles.
